IP Library Granted Patent US 6,921,529
Granted Patent B2
US 6,921,529 · App. 10/207,936 · Granted Jul 26, 2005

Treatment modality and method for fungal nail infection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,921,529
App. No.
10/207,936
Granted
Jul 26, 2005
Kind
B2
Abstract

A method of treatment of onychomychosis wherein a hydrogel is supersaturated with an antimycotic agent and supported on a backing. The assembly is placed over an infected nail for an extended period of time. The antimycotic agent diffuses through the nail to the underlying infection.

Claims (29)

1. A method of treating a nail infected with onychomycosis comprising,

contacting an infected nail with a patch consisting of a cross-linked hydrogel wherein an organic acid solution is dispersed in the hydrogel.

2. The method according to claim 1 wherein the organic acid solution comprises citric acid.

3. The method according to claim 1 , further comprising a supportive backing on a surface of the hydrogel.

4. The method according to claim 3 wherein the supportive backing is shaped to conform to an upper surface of an infected nail.

5. A method of treating a nail infected with onychomycosis, comprising,

contacting an infected nail with a patch consisting of a cross-linked hydrogel wherein an organic acid solution is dispersed in the hydrogel, and diffusing the organic acid solution through at least a portion of the infected nail.

6. The method according to claim 5 wherein the organic acid solution comprises acetic acid.

7. The method according to claim 5 further comprising a supportive backing on a surface of the hydrogel.

8. The method according to claim 7 wherein the supportive backing is shaped to conform to an upper surface of an infected nail.

9. A treatment agent for an infected nail, consisting of:

a supersaturated polymeric hydrogel;

an organic acid dispersed in the hydrogel;

a membrane to cover one surface of the hydrogel to form a patch; and

an adhesive coupled one surface of the patch to attach the patch to the nail.

10. The treatment agent of claim 9 wherein the organic acid is acetic acid.

11. The treatment agent of claim 9 wherein the organic acid is citric acid.

12. The treatment agent of claim 9 wherein the hydrogel is a polyacrylate.

13. A treatment agent, consisting of:

a supersaturated polymeric hydrogel;

an antimycotic agent dispersed in the hydrogel;

wherein the antimycotic agent is citric acid, acetic acid, iodine, DMSO, undecylenic acid, tea tree oil, salicylic acid, or urea;

a membrane to cover one surface of the hydrogel to form a patch; and

an adhesive coupled to one surface of the patch to attach the patch to the nail.

14. The treatment agent of claim 13 wherein the hydrogel is a polyacrylate.

15. The method of claim 1 wherein contacting further comprises adhering the cross-linked hydrogel to the infected nail.

16. The method of claim 5 wherein contacting further comprises adhering the cross-linked hydrogel to the infected nail.

17. The method according to claim 1 wherein the organic acid solution comprises acetic acid.

18. The method according to claim 5 wherein the organic acid solution comprises citric acid.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034753/0001 →